Approval · Notice of Compliance 25125 · 2021
PROFENDER: Notice of Compliance 25125
Issued February 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25125
- Date
- February 2, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROFENDER | 02316137 | Marketed |
Medicinal ingredients
- PRAZIQUANTEL 30 MG per 0.35ML
- EMODEPSIDE 7.5 MG per 0.35ML